Abeona Therapeutics Inc Cash Flow Quality Index
Abeona Therapeutics Inc cash flow quality index. Abeona Therapeutics Inc (ABEO) has a Cash Flow Quality Index of -0.17x as of June 2025. Operating cash flow of $-18.78 Million is below net income of $108.83 Million, suggesting accrual-heavy earnings not yet converted to cash. See Abeona Therapeutics Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Abeona Therapeutics Inc (1995–2025)
Cash flow quality index of Abeona Therapeutics Inc from 1995 to 2025. Historical Cash Flow Quality Index for Abeona Therapeutics Inc across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore ABEO operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Abeona Therapeutics Inc Cash Flow Quality Index by Year (1995–2025)
Abeona Therapeutics Inc cash flow quality index by year from 1995 to 2025. Year-by-year earnings quality comparison for Abeona Therapeutics Inc. For the full cash flow conversion analysis, see ABEO operating cash flow.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -1.07x | $-76.33 Million | $71.18 Million | ▼ -477144.2% |
| 2013 | 0.00x | $1.00K | $4.45 Million | ▼ -100.0% |
| 1995 | 1.93x | $658.00K | $341.00K | — |